model: gpt-4-1106-preview
prompt: Write a paragraph of text in the style of a biomedical research article. Include the following protein complex name: RNAPII. Use this name exactly as provided, avoiding any synonyms, aliases, abbreviated or expanded forms. Also avoid including any other names referring to a gene, protein, protein complex, protein part or component, or any other molecular entity containing amino acid residues. The text can include mentions of other biomedical entity types, such as chemical, organism, and disease names.
output: Recent advances in chromatin immunoprecipitation followed by sequencing (ChIP-seq) methodologies have allowed investigators to map the genomic distribution of RNAPII with unprecedented resolution, providing invaluable insights into the transcriptional landscape of a variety of model organisms. The interaction between RNAPII and DNA has been extensively characterized in the context of gene expression regulation, revealing complex patterns of RNAPII occupancy that correlate with various stages of transcription and post-transcriptional modifications. Particularly, the phosphorylation of the RNAPII C-terminal domain serves as a dynamic regulatory mechanism during the transcription cycle, facilitating the transition from transcription initiation to elongation, as well as recruiting factors necessary for mRNA splicing and processing. The perturbation of RNAPII dynamics has been implicated in the pathology of several diseases, including cancer and neurodegenerative disorders, in which aberrant transcriptional profiles contribute to disease phenotype and progression. Moreover, small molecule inhibitors targeting the interaction between RNAPII and specific regulatory proteins show therapeutic potential, thus underscoring the importance of RNAPII as a focal point for the development of novel pharmacological interventions. These studies highlight the pivotal role of RNAPII in both the intricate regulation of eukaryotic gene expression and as a critical target for drug discovery.
